Okegawa, T.; Itaya, N.; Hara, H.; Tambo, M.; Nutahara, K.
Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy. Int. J. Mol. Sci. 2016, 17, 2008.
https://doi.org/10.3390/ijms17122008
AMA Style
Okegawa T, Itaya N, Hara H, Tambo M, Nutahara K.
Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy. International Journal of Molecular Sciences. 2016; 17(12):2008.
https://doi.org/10.3390/ijms17122008
Chicago/Turabian Style
Okegawa, Takatsugu, Naoshi Itaya, Hidehiko Hara, Mitsuhiro Tambo, and Kikuo Nutahara.
2016. "Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy" International Journal of Molecular Sciences 17, no. 12: 2008.
https://doi.org/10.3390/ijms17122008
APA Style
Okegawa, T., Itaya, N., Hara, H., Tambo, M., & Nutahara, K.
(2016). Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy. International Journal of Molecular Sciences, 17(12), 2008.
https://doi.org/10.3390/ijms17122008
